… To assess the effectiveness of the HPV vaccines in preventing genital warts (GW) in women
aged 14–23 years and to estimate the incidence of GW in the whole population aged from …

… the age of 17–19 years old and in fully vaccinated women only after 19 years of age. Similar
… was 9–11 years old. This systematic review reveals that the incidence of GWs among HPV-…

… warts. Therefore, the category of disease-associated HPV, which includes the HPV types
detected during cervical cancer screening and that cause genital warts, encompasses …

… (HPV) vaccination may protect significantly against HPV-related disease. We provide
nationwide, real-world data on the risk of genital warts (GWs) after <3 vaccine doses. …

… Age-specific incidence rates of genital warts in Danish women and men aged 15–49 years
during 1996–2016, shown separately for persons with type 1 diabetes and persons without …

… The quadrivalent human papillomavirus (HPV) vaccine was introduced … -year-old girls. This
study aimed at evaluating the impact of HPV vaccination on the epidemiology of genital warts …

… the following search terms: (genital warts or genital wart or anogenital warts or anogenital …
4 Nordic countries, smoking for >59 pack-years increased the probability of reporting AGWs. A …

… Only one study from Australia evaluated the difference in reduction of genital warts between
… genital warts trend up until 2009, within two years of the implementation of the national HPV …

… The quadrivalent human papillomavirus (HPV) vaccine has been assumed to give protection
against genital warts (GW) as well as cervical cancer. Our main question was whether HPV …

… significantly decreased in the presence of genital warts (23.82 ± 9.73 (… This study revealed
that genital warts have significantly … increase success in clinical management of genital warts. …